Obesity: The disease

Journal of Medicinal Chemistry

Volumn 49, Issue 14, 2006, Pages 4001-4007

  Bray, George A ^a,b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMFEPRAMONE; ANTIOBESITY AGENT; BENZPHETAMINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID RECEPTOR ANTAGONIST; EPHEDRINE; METFORMIN; PHENDIMETRAZINE; RECOMBINANT CILIARY NEUROTROPHIC FACTOR; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE; ZONISAMIDE;

CLINICAL TRIAL; COST OF ILLNESS; DRUG APPROVAL; HUMAN; HYPERTENSION; OBESITY; PREVALENCE; RISK FACTOR; SHORT SURVEY; UNSPECIFIED SIDE EFFECT;

BODY MASS INDEX; HUMANS; OBESITY; PREVALENCE;

EID: 33745807267     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0680124     Document Type: Short Survey

References (103)

1. Bray, G. A. Obesity is a chronic, relapsing neurochemical disease. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 34-38.
2. Bray, G. A.; Champagne, C. M. Beyond energy balance: there is more to obesity than kilocalories. J. Am. Diet. Assoc. 2005, 105, 17-23.
3. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report. National Institutes of Health. Obes. Res. 1998, 6 (Suppl. 2), 51S-209S.
4. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. W. H. O. Tech. Rep. Ser. 2000, 894, i-xii, 1-253.
5. Janssen, I.; Katzmarzyk, P. T.; Ross, R. Waist circumference and not body mass index explains obesity-related health risk. Am. J. Clin. Nutr. 2004, 79, 379-384.
6. Bray, G. A. Don't throw the baby out with the bath water. Am. J. Clin. Nutr. 2004, 79, 347-349.
7. Flegal, K. M.; Carroll, M. D.; Ogden, C. L.; Johnson, C. L. Prevalence and trends in obesity among U.S. adults, 1999-2000. JAMA, J. Am. Med. Assoc. 2002, 288, 1723-1727.
8. Ogden, C. L.; Flegal, K. M.; Carroll, M. D.; Johnson, C. L. Prevalence and trends in overweight among U.S. children and adolescents, 1999-2000. JAMA, J. Am. Med. Assoc. 2002, 288, 1728-32.
9. National Center for Health Statistics, http://www.cdc.gov/nchs/ (November 23).
10. Finkelstein, E. A.; Fiebelkorn, I. C.; Wang, G. State-level estimates of annual medical expenditures attributable to obesity. Obes. Res. 2004, 12, 18-24.
11. Quesenberry, C. P., Jr.; Caan, B.; Jacobson, A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch. Intern. Med. 1998, 158, 466-472.
12. Thompson, D.; Edelsberg, J.; Colditz, G. A.; Bird, A. P.; Oster, G. Lifetime health and economic consequences of obesity. Arch. Intern. Med. 1999, 159, 2177-2183.
13. Bray, G. A.; Champagne, C. M. Beyond energy balance: there's more to obesity than calories. J. Am. Diet. Assoc., in press.
14. Dabelea, D.; Pettitt, D. J.; Hanson, R. L.; Imperatore, G.; Bennett, P. H.; Knowler, W. C. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care 1999, 22, 944-950.
15. Toschke, A. M.; Ehlin, A. G.; von Kries, R.; Ekbom, A.; Montgomery, S. M. Maternal smoking during pregnancy and appetite control in offspring. J. Perinat. Med. 2003, 31, 251-256.
16. Bhargava, S. K.; Sachdev, H. S.; Fall, C. H.; Osmond, C.; Lakshmy, R.; Barker, D. J.; Biswas, S. K.; Ramji, S.; Prabhakaran, D.; Reddy, K. S. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N. Engl. J. Med. 2004, 350, 865-875.
17. Ailhaud, G.; Guesnet, P. Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion. Obes. Rev. 2004, 5, 21-26.
18. von Kries, R.; Koletzko, B.; Sauerwald, T.; von Mutius, E.; Barnert, D.; Grunert, V.; von Voss, H. Breast feeding and obesity: cross sectional study. BMJ 1999, 319, 147-150.
19. Whitaker, R. C.; Pepe, M. S.; Wright, J. A.; Seidel, K. D.; Dietz, W. H. Early adiposity rebound and the risk of adult obesity. Pediatrics 1998, 101, E5.
20. Dietz, W. H. Childhood weight affects adult morbidity and mortality. J. Nutr. 1998, 128, 411S-414S.
21. Kroeze, W. K.; Hufeisen, S. J.; Popadak, B. A.; Renock, S. M.; Steinberg, S.; Ernsberger, P.; Jayathilake, K.; Meltzer, H. Y.; Roth, B. L. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 2003, 28, 519-526.
22. Young, L. R.; Nestle, M. The contribution of expanding portion sizes to the U.S. obesity epidemic. Am. J. Public Health 2002, 92, 246-249.
23. Rolls, B. J.; Morris, E. L.; Roe, L. S. Portion size of food affects energy intake in normal-weight and overweight men and women. Am. J. Clin. Nutr. 2002, 76, 1207-1213.
24. Bray, G. A.; Popkin, B. M. Dietary fat intake does affect obesity! Am. J. Clin. Nutr. 1998, 68, 1157-1173.
25. Astrup, A.; Ryan, L.; Grunwald, G. K.; Storgaard, M.; Saris, W.; Melanson, E.; Hill, J. O. The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br. J. Nutr. 2000, 83 (Suppl. 1), S25-S32.
26. Bray, G. A.; Nielsen, S. J.; Popkin, B. M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 2004, 79, 537-543.
27. Bray, G. A. The epidemic of obesity and changes in food intake: the fluoride hypothesis. Physiol. Behav. 2004, 82, 115-121.
28. Ludwig, D. S.; Peterson, K. E.; Gortmaker, S. L. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 2001, 357, 505-508.
29. Raben, A.; Vasilaras, T. H.; Moller, A. C.; Astrup, A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am. J. Clin. Nutr. 2002, 76, 721-729.
30. Schulze, M. B.; Manson, J. E.; Ludwig, D. S.; Colditz, G. A.; Stampfer, M. J.; Willett, W. C.; Hu, F. B. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA, J. Am. Med. Assoc. 2004, 292, 927-934.
31. Williamson, D. F.; Madans, J.; Anda, R. F.; Kleinman, J. C.; Kahn, H. S.; Byers, T. Recreational physical activity and ten-year weight change in a U.S. national cohort. Int. J. Obes. Relat. Metab. Disord. 1993, 17, 279-286.
32. Ravussin, E.; Lillioja, S.; Knowler, W. C.; Christin, L.; Freymond, D.; Abbott, W. G.; Boyce, V.; Howard, B. V.; Bogardus, C. Reduced rate of energy expenditure as a risk factor for body-weight gain. N. Engl. J. Med. 1988, 318, 467-472.
33. Church, T. S.; Cheng, Y. J.; Earnest, C. P.; Barlow, C. E.; Gibbons, L. W.; Priest, E. L.; Blair, S. N. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care 2004, 27, 83-88.
34. Gortmaker, S. L.; Must, A.; Sobol, A. M.; Peterson, K.; Colditz, G. A.; Dietz, W. H. Television viewing as a cause of increasing obesity among children in the United States, 1986-1990. Arch. Pediatr. Adolesc. Med. 1996, 150, 356-362.
35. O'Hara, P.; Connett, J. E.; Lee, W. W.; Nides, M.; Murray, R.; Wise, R. Early and late weight gain following smoking cessation in the Lung Health Study. Am. J. Epidemiol. 1998, 148, 821-830.
36. Dhurandhar, N. V.; Kulkarni, P. R.; Ajinkya, S. M.; Sherikar, A. A.; Atkinson, R. L. Association of adenovirus infection with human obesity. Obes. Res. 1997, 5, 464-469.
37. Farooqi, I. S.; Keogh, J. M.; Yeo, G. S.; Lank, E. J.; Cheetham, T.; O'Rahilly, S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 2003, 348, 1085-1095.
38. Farooqi, I. S.; Keogh, J. M.; Kamath, S.; Jones, S.; Gibson, W. T.; Trussell, R.; Jebb, S. A.; Lip, G. Y.; O'Rahilly, S. Partial leptin deficiency and human adiposity. Nature 2001, 414, 34-35.
39. Rosenbaum, M.; Murphy, E. M.; Heymsfield, S. B.; Matthews, D. E.; Leibel, R. L. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J. Clin. Endocrinol. Metab. 2002, 87, 2391-2394.
40. Ohta, T.; Gray, T. A.; Rogan, P. K.; Buiting, K.; Gabriel, J. M.; Saitoh, S.; Muralidhar, B.; Bilienska, B.; Krajewska-Walasek, M.; Driscoll, D. J.; Horsthemke, B.; Butler, M. G.; Nicholls, R. D. Imprinting-mutation mechanisms in Prader-Willi syndrome. Am. J. Hum. Genet. 1999, 64, 397-413.
41. Fan, Y.; Esmail, M. A.; Ansley, S. J.; Blacque, O. E.; Boroevich, K.; Ross, A. J.; Moore, S. J.; Badano, J. L.; May-Simera, H.; Compton, D. S.; Green, J. S.; Lewis, R. A.; van Haelst, M. M.; Parfrey, P. S.; Baillie, D. L.; Beales, P. L.; Katsanis, N.; Davidson, W. S.; Leroux, M. R. Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat. Genet. 2004, 36, 989-993.
42. Snyder, E. E.; Walts, B.; Perusse, L.; Chagnon, Y. C.; Weisnagel, S. J.; Rankinen, T.; Bouchard, C. The human obesity gene map: the 2003 update. Obes. Res. 2004, 12, 369-439.
43. Cummings, D. E.; Schwartz, M. W. Genetics and pathophysiology of human obesity. Annu. Rev. Med. 2003, 54, 453-471.
44. Pissios, P.; Maratos-Flier, E. Melanin-concentrating hormone: from fish skin to skinny mammals. Trends Endocrinol. Metab. 2003, 14, 243-248.
45. Di Marzo, V.; Bifulco, M.; De Petrocellis, L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discovery 2004, 3, 771-784.
46. Di Marzo, V.; Goparaju, S. K.; Wang, L.; Liu, J.; Batkai, S.; Jarai, Z.; Fezza, F.; Miura, G. I.; Palmiter, R. D.; Sugiura, T.; Kunos, G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410, 822-825.
47. Cota, D.; Marsicano, G.; Tschop, M.; Grubler, Y.; Flachskamm, C.; Schubert, M.; Auer, D.; Yassouridis, A.; Thone-Reineke, C.; Ortmann, S.; Tomassoni, F.; Cervino, C.; Nisoli, E.; Linthorst, A. C.; Pasquali, R.; Lutz, B.; Stalla, G. K.; Pagotto, U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 2003, 112, 423-431.
48. Ravinet Trillou, C.; Delgorge, C.; Menet, C.; Arnone, M.; Soubrie, P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 640-648.
49. Batterham, R. L.; Cohen, M. A.; Ellis, S. M.; Le Roux, C. W.; Withers, D. J.; Frost, G. S.; Ghatei, M. A.; Bloom, S. R. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 2003, 349, 941-948.
50. Hu, Z.; Cha, S. H.; Chohnan, S.; Lane, M. D. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc. Natl. Acad. Sci. U.S.A 2003, 100, 12624-12629.
51. Obici, S.; Rossetti, L. Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 2003, 144, 5172-5178.
52. Bray, G. A. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 2004, 89, 2583-2589.
53. Kanaya, A. M.; Vittinghoff, E.; Shlipak, M. G.; Resnick, H. E.; Visser, M.; Grady, D.; Barrett-Connor, E. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am. J. Epidemiol. 2003, 158, 1161-1170.
54. Park, Y. W.; Zhu, S.; Palaniappan, L.; Heshka, S.; Carnethon, M. R.; Heymsfield, S. B. The metabolic syndrome: prevalence and associated risk factor findings in the U.S. population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2003, 163, 427-436.
55. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, J. Am. Med. Assoc. 2001, 285, 2486-2497.
56. Mokdad, A. H.; Ford, E. S.; Bowman, B. A.; Dietz, W. H.; Vinicor, F.; Bales, V. S.; Marks, J. S. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA, J. Am. Med. Assoc. 2003, 289, 76-79.
57. Peelers, A.; Barendregt, J. J.; Willekens, F.; Mackenbach, J. P.; Al Mamun, A.; Bonneux, L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann. Intern. Med. 2003, 138, 24-32.
58. Fontaine, K. R.; Redden, D. T.; Wang, C.; Westfall, A. O.; Allison, D. B. Years of life lost due to obesity. JAMA, J. Am. Med. Assoc. 2003, 289, 187-193.
59. Calle, E. E.; Thun, M. J.; Petrelli, J. M.; Rodriguez, C.; Heath, C. W., Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 1999, 341, 1097-1105.
60. Calle, E. E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003, 348, 1625-1638.
61. Weisberg, S. P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R. L.; Ferrante, A. W., Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
62. Tchernof, A.; Nolan, A.; Sites, C. K.; Ades, P. A.; Poehlman, E. T. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002, 105, 564-569.
63. Robinson, T. N. Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 1999, 282, 1561-1567.
64. James, J.; Thomas, P.; Cavan, D.; Kerr, D. Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. BMJ 2004, 328, 1237.
65. Foster, G. D.; Wadden, T. A.; Vogt, R. A.; Brewer, G. What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. J. Consult. Clin. Psychol. 1997, 65, 79-85.
66. Sjostrom, L.; Lindroos, A. K.; Peltonen, M.; Torgerson, J.; Bouchard, C.; Carlsson, B.; Dahlgren, S.; Larsson, B.; Narbro, K.; Sjostrom, C. D.; Sullivan, M.; Wedel, H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. 2004, 351, 2683-2693.
67. Knowler, W. C.; Barrett-Connor, E.; Fowler, S. E.; Hamman, R. F.; Lachin, J. M.; Walker, E. A.; Nathan, D. M. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346, 393-403.
68. Flechtner-Mors, M.; Ditschuneit, H. H.; Johnson, T. D.; Suchard, M. A.; Adler, G. Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Obes. Res. 2000, 8, 399-402.
69. Freedman, M. R.; King, J.; Kennedy, E. Popular diets: a scientific review. Obes. Res. 2001, 9 (Suppl. 1), 1S-40S.
70. Pirozzo, S.; Summerbell, C.; Cameron, C.; Glasziou, P. Should we recommend low-fat diets for obesity? Obes. Rev. 2003, 4, 83-90.
71. Hays, N. P.; Starling, R. D.; Liu, X.; Sullivan, D. H.; Trappe, T. A.; Fluckey, J. D.; Evans, W. J. Effects of an ad libitum low-fat, high-carbohydrate diet on body weight, body composition, and fat distribution in older men and women: a randomized controlled trial. Arch. Intern. Med. 2004, 164, 210-217.
72. Foster, G. D.; Wyatt, H. R.; Hill, J. O.; McGuckin, B. G.; Brill, C.; Mohammed, B. S.; Szapary, P. O.; Rader, D. J.; Edman, J. S.; Klein, S. A randomized trial of a low-carbohydrate diet for obesity. N. Engl. J. Med. 2003, 348, 2082-2090.
73. Samaha, F. F.; Iqbal, N.; Seshadri, P.; Chicano, K. L.; Daily, D. A.; McGrory, J.; Williams, T.; Williams, M.; Gracely, E. J.; Stern, L. A low-carbohydrate as compared with a low-fat diet in severe obesity. N. Engl. J. Med. 2003, 348, 2074-2081.
74. Brehm, B. J.; Seeley, R. J.; Daniels, S. R.; D'Alessio, D. A. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J. Clin. Endocrinol. Metab. 2003, 88, 1617-1623.
75. Bravata, D. M.; Sanders, L.; Huang, J.; Krumholz, H. M.; Olkin, I.; Gardner, C. D. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA, J. Am. Med. Assoc. 2003, 289, 1837-1850.
76. Stern, L.; Iqbal, N.; Seshadri, P.; Chicano, K. L.; Daily, D. A.; McGrory, J.; Williams, M.; Gracely, E. J.; Samaha, F. F. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann. Intern. Med. 2004, 140, 778-785.
77. Dansinger, M. L.; Gleason, J. A.; Griffith, J. L.; Selker, H. P.; Schaefer, E. J. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA, J. Am. Med. Assoc. 2005, 293, 43-53.
78. Jakicic, J. M.; Marcus, B. H.; Gallagher, K. I.; Napolitano, M.; Lang, W. Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial. JAMA. J. Am. Med. Assoc. 2003, 290, 1323-1330.
79. Tate, D. F.; Jackvony, E. H.; Wing, R. R. Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA. J. Am. Med. Assoc. 2003, 289, 1833-1836.
80. Padwal, R.; Li, S. K.; Lau, D. C. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int. J. Obes. Relat. Metab. Disord. 2003, 27, 1437-1446.
81. McMahon, F. G.; Fujioka, K.; Singh, B. N.; Mendel, C. M.; Rowe, E.; Rolston, K.; Johnson, F.; Mooradian, A. D. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch. Intern. Med. 2000, 160, 2185-2191.
82. McMahon, F. G.; Weinstein, S. P.; Rowe, E.; Ernst, K. R.; Johnson, F.; Fujioka, K. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. J. Hum. Hypertens. 2002, 16, 5-11.
83. James, W. P.; Astrup, A.; Finer, N.; Hilsted, J.; Kopelman, P.; Rossner, S.; Saris, W. H.; Van Gaal, L. F. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine trial of obesity reduction and maintenance. Lancet 2000, 356, 2119-2125.
84. Sjostrom, L.; Rissanen, A.; Andersen, T.; Boldrin, M.; Golay, A.; Koppeschaar, H. P.; Krempf, M. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998, 352, 167-172.
85. Davidson, M. H.; Hauptman, J.; DiGirolamo, M.; Foreyt, J. P.; Halsted, C. H.; Heber, D.; Heimburger, D. C.; Lucas, C. P.; Robbins, D. C.; Chung, J.; Heymsfield, S. B. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 1999, 281, 235-242.
86. Hauptman, J.; Lucas, C.; Boldrin, M. N.; Collins, H.; Segal, K. R. Orlistat in the long-term treatment of obesity in primary care settings. Arch. Fam. Med. 2000, 9, 160-167.
87. Rossner, S.; Sjostrom, L.; Noack, R.; Meinders, A. E.; Noseda, G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes. Res. 2000, 8, 49-61.
88. Torgerson, J. S.; Hauptman, J.; Boldrin, M. N.; Sjostrom, L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004, 27, 155-161.
89. Wadden, T. A.; Berkowitz, R. I.; Womble, L. G.; Sarwer, D. B.; Arnold, M. E.; Steinberg, C. M. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial. Obes. Res. 2000, 8, 431-437.
90. Shekelle, P. G.; Hardy, M. L.; Morton, S. C.; Maglione, M.; Mojica, W. A.; Suttorp, M. J.; Rhodes, S. L.; Jungvig, L.; Gagne, J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA, J. Am. Med. Assoc. 2003, 289, 1537-1545.
91. McBride, B. F.; Karapanos, A. K.; Krudysz, A.; Kluger, J.; Coleman, C. I.; White, C. M. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 2004, 291, 216-221.
92. Anderson, J. W.; Greenway, F. L.; Fujioka, K.; Gadde, K. M.; McKenney, J.; O'Neil, P. M. Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial. Obes. Res. 2002, 10, 633-641.
93. Bray, G. A.; Hollander, P.; Klein, S.; Kushner, R.; Levy, B.; Fitchet, M.; Perry, B. H. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes. Res. 2003, 11, 722-733.
94. Gadde, K. M.; Franciscy, D. M.; Wagner, H. R., 2nd; Krishnan, K. R. Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 2003, 289, 1820-1825.
95. Ettinger, M. P.; Littlejohn, T. W.; Schwartz, S. L.; Weiss, S. R.; McIlwain, H. H.; Heymsfield, S. B.; Bray, G. A.; Roberts, W. G.; Heyman, E. R.; Stambler, N.; Heshka, S.; Vicary, C.; Guler, H. P. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA, J. Am. Med. Assoc. 2003, 289, 1826-1832.
96. Després, J.-P.; Golay, A.; et al. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 2005, 353, (20), 2121-2134.
97. Pi-Sunyer, F. X.; Aronne, L. J.; et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA. J. Am. Med. Assoc. 2006, 295, (7), 761-775.
98. Jessen, A. B.; Toubro, S.; Astrup, A. Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men. Am. J. Clin. Nutr. 2003, 77, 1442-1447.
99. Steinbrook, R. Surgery for severe obesity. N. Engl. J. Med. 2004, 350, 1075-1079.
100. Sjostrom, C. D.; Lissner, L.; Wedel, H.; Sjostrom, L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes. Res. 1999, 7, 477-484.
101. Flum, D. R.; Dellinger, E. P. Impact of gastric bypass operation on survival: a population-based analysis. J. Am. Coll. Surg. 2004, 199, 543-551.
102. Christou, N. V.; Sampalis, J. S.; Liberman, M.; Look, D.; Auger, S.; McLean, A. P.; MacLean, L. D. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann. Surg. 2004, 240, 416-423 (discussion on pp 423-424).
103. Buchwald, H.; Avidor, Y.; Braunwald, E.; Jensen, M. D.; Pories, W.; Fahrbach, K.; Schoelles, K. Bariatric surgery: a systematic review and meta-analysis. JAMA, J. Am. Med. Assoc. 2004, 292, 1724-1737.